Robin Sherrington
Corporate Officer/Principal bei XENON PHARMACEUTICALS INC.
Vermögen: 336 760 $ am 30.04.2024
Profil
Robin Sherrington currently works at Xenon Pharmaceuticals, Inc., as Executive Vice President-Strategy & Innovation from 2019.
Dr. Sherrington also formerly worked at Pfizer Inc., as Neuroscience Director from 1999 to 2001, Sequana Therapeutics, Inc., as Neuroscience Director from 1996 to 1999, Axys Pharmaceuticals, Inc., as Neuroscience Director from 1996 to 1999, and Parke-Davis & Co. Ltd., as Neuroscientist.
Dr. Sherrington received his undergraduate degree from The University of Reading and doctorate degree from University College London.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.03.2024 | 8 398 ( 0,01% ) | 336 760 $ | 30.04.2024 |
Aktive Positionen von Robin Sherrington
| Unternehmen | Position | Beginn |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Corporate Officer/Principal | 01.03.2019 |
Ehemalige bekannte Positionen von Robin Sherrington
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01.01.2001 |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.1999 |
Sequana Therapeutics, Inc.
 Sequana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sequana Therapeutics Inc. is a leading genomics company that uses industrial-scale gene-finding technologies and functional genomics to develop products aimed at diagnosing and treating common human diseases | Corporate Officer/Principal | 01.01.1999 |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The private company is based in St. Helier, UK. | Corporate Officer/Principal | - |
Ausbildung von Robin Sherrington
| University College London | Doctorate Degree |
| The University of Reading | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| XENON PHARMACEUTICALS INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Health Technology |
Sequana Therapeutics, Inc.
Sequana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sequana Therapeutics Inc. is a leading genomics company that uses industrial-scale gene-finding technologies and functional genomics to develop products aimed at diagnosing and treating common human diseases | Commercial Services |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The private company is based in St. Helier, UK. | Health Technology |
